Our mobile device connected sedation monitor reduces staff workload and bedside contact, while improving patient care.
Apps that run on any mobile phone while monitoring multiple devices make iTOF easy to use, easy to deploy, and available anywhere, anytime.
HIPAA compliant data logging and AI-assisted analysis along with software updates.
Dr. Sebastián Monsalves
Anesthesiologist of San Borja Arriarán Clinical Hospital and Clinica Alemana.
President of the Airway Committee, Chilean Society of Anesthesiology (SACH).
"I have been using iTOF for approximately ten weeks in the context of the COVID-19 pandemic... I can say that the iTOF registers are very reliable, and the user interface is user-friendly."
In context, COVID-19 iTOF has been a significant contribution. In our hospital, monitors are scarce. For the implementation of new critical units, simply non-existent or unattainable by cost, to date are in uninterrupted use in critical patient units COVID-19 of the Hospital San Borja Arriarán.
Additionally, iTOF offers a significant advantage over other devices. Efficient user monitoring, remotely, from the security zone to meters of a patient's room COVID-19, has unique benefits.
We are reducing the exposure of personnel to monitor neuromuscular relaxation. Minimize the usage and expenses of personal protective equipment used for neuromuscular relaxation monitoring.
Therefore promote the use of the equipment; this is probably a consequence of reducing direct exposure to the COVID-19 patient room and benefits patients in the severe distress phase and the weaning phase during this pandemic.
Dr. David Barra Ortiz
Anesthesiology at Hospital Clinico San Borja Arriarán, Santiago Chile.
Member of the Chilean Society of Anesthesiology (SACH).
"I used the iTOF approximately four weeks to monitor neuromuscular blockade in hospitalized patients in our intensive care units amid the COVID-19 pandemic."
During this time, our critical patient beds have doubled, even tripled, in a minimal period, with all its implications. The COVID-19 pandemic has significantly increased patients with severe respiratory distress syndrome, making it necessary to carry out highly complex therapies. Neuromuscular blockade in these patients, according to national and international guidelines today, strongly suggest quantitative monitoring.
The monitor has a suitable size, easy to install, a very efficient interface for remote monitoring of patients carrying COVID-19, presenting:
1. Easy use of applications with smartphones.
2. Monitoring almost continuously.
3. Various monitoring modes (DBS, PTC, TOF) allow for assessment more accurately and allow a better dosage of medications.
4. Less exposure of health personnel in monitoring neuromuscular blockade.
5. Less use of personal protection elements as you do not need to enter the care box to control neuromuscular block.
6. Our nursing staff has widely accepted it."
Nerbio Medical Software Platforms, Inc.
1900 Camden Ave , San Jose, CA 95124 USA
Contact +1 (408) 809 3296
Nerbio® and iTOF® are registered trademarks of Nerbio Medical Software Platforms, Inc. Copyright © 2021 Nerbio - All Rights Reserved.